{"disease":{"id":"facioscapulohumeral-muscular-dystrophy","name":"facioscapulohumeral muscular dystrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05295277","title":"Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Bionano Genomics","has_results":false},{"nct_id":"NCT05397470","title":"Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":260,"lead_sponsor_name":"Fulcrum Therapeutics","has_results":true},{"nct_id":"NCT06911190","title":"Ten Year Follow-up in FSHD: the FOCUS 3 Study","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT06917430","title":"Muscle MRI Outlining of Neuromuscular Diseases Using Artificial Intelligence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT04907162","title":"Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"LMU Klinikum","has_results":false},{"nct_id":"NCT04003974","title":"Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Fulcrum Therapeutics","has_results":true},{"nct_id":"NCT04264442","title":"Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":76,"lead_sponsor_name":"Fulcrum Therapeutics","has_results":true},{"nct_id":"NCT05812144","title":"New Clinical Outcome Measures to Remotely Evaluate Patients With FacioScapuloHumeral Muscular Dystrophy","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT03943290","title":"Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":62,"lead_sponsor_name":"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA","has_results":true},{"nct_id":"NCT01596803","title":"Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05548556","title":"A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":51,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT07164937","title":"Imaging and Gait Analysis in FSHD Patients","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":40,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07331025","title":"Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Koç University","has_results":false},{"nct_id":"NCT05178706","title":"Effectiveness of Upper Extremity Rehabilitation in pwFSHD (Patient With Facioscapulohumeral Dystrophia)","phase":"","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT06425445","title":"Quantitative Assessment of Orofacial Muscle Function in FSHD","phase":"NA","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"University of Mons","has_results":false},{"nct_id":"NCT02239224","title":"Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"aTyr Pharma, Inc.","has_results":true},{"nct_id":"NCT03123913","title":"Study of Testosterone and rHGH in FSHD","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of Rochester","has_results":true},{"nct_id":"NCT02579239","title":"Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"aTyr Pharma, Inc.","has_results":true},{"nct_id":"NCT04267354","title":"Arm Cycling in Facioscapulohumeral Dystrophy (FSHD) Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust","has_results":false},{"nct_id":"NCT04004000","title":"Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"Fulcrum Therapeutics","has_results":true},{"nct_id":"NCT06907875","title":"A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Epicrispr Biotechnologies, Inc.","has_results":false},{"nct_id":"NCT02531217","title":"Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"aTyr Pharma, Inc.","has_results":true},{"nct_id":"NCT04154098","title":"Evaluation of a Textile Scapula Orthosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Swiss Federal Institute of Technology","has_results":false},{"nct_id":"NCT02603562","title":"Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"aTyr Pharma, Inc.","has_results":true},{"nct_id":"NCT02836418","title":"Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"aTyr Pharma, Inc.","has_results":true}],"total":25},"guidelines":[],"source":"Drug Landscape verified database"}